4588 — Oncolys Biopharma Share News
0.000.00%
- ¥175bn
- ¥173bn
- ¥29m
Table: Oncolys Biopharma - Q1 parent results
Table: Oncolys Biopharma -2025 parent results
Table: Oncolys Biopharma - 9-MTH parent results
Table: Oncolys Biopharma - 6-MTH parent results
Table: Oncolys Biopharma - Q1 parent results
Table: Oncolys Biopharma -2024 parent results
Table: Oncolys Biopharma - Q1 parent results
Table: Oncolys Biopharma -2023 parent results
Table: Oncolys Biopharma -2023 parent forecast
Table: Oncolys Biopharma - 9-MTH parent results
Table: Oncolys Biopharma - 6-MTH parent results
Table: Oncolys Biopharma - Q1 parent results
Table: Oncolys Biopharma -2022 parent results
Table: Oncolys Biopharma - 9-MTH parent results
Table: Oncolys Biopharma - 6-MTH parent results
Table: Oncolys Biopharma - Q1 parent results
Table: Oncolys Biopharma -2021 parent results
Table: Oncolys Biopharma -2021 parent forecast
Table: Oncolys Biopharma - 9-MTH parent results